Cargando…

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases

The oral poliovirus vaccine (OPV), which prevents person-to-person transmission of poliovirus by inducing robust intestinal immunity, has been a crucial tool for global polio eradication. However, polio outbreaks, mainly caused by type 2 circulating vaccine-derived poliovirus (cVDPV2), are increasin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitamura, Kouichi, Shimizu, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310373/ https://www.ncbi.nlm.nih.gov/pubmed/34372613 http://dx.doi.org/10.3390/v13071407

Ejemplares similares

Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China
por: Guo, Qin, et al.
Publicado: (2023)

Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
por: Shaghaghi, Mohammadreza, et al.
Publicado: (2016)

Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
por: Gumede, Nicksy, et al.
Publicado: (2012)

Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy
por: DUINTJER TEBBENS, R. J., et al.
Publicado: (2017)

Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran
por: Shaghaghi, Mohammadreza, et al.
Publicado: (2019)

Poliovirus surveillance in patients with primary immunodeficiencies, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2023)

Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?
por: Zhao, Kun, et al.
Publicado: (2017)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children
por: Singanayagam, Anika, et al.
Publicado: (2023)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2017)

Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
por: Macklin, Grace, et al.
Publicado: (2020)

Emergence of vaccine-derived poliovirus type 2 after using monovalent type 2 oral poliovirus vaccine in an outbreak response, Philippines
por: Alipon, SweetC B, et al.
Publicado: (2022)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
por: Macklin, Grace, et al.
Publicado: (2017)

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks()
por: Estivariz, Concepcion F., et al.
Publicado: (2023)

Detection of a Highly Divergent Type 3 Vaccine-Derived Poliovirus in a Child with a Severe Primary Immunodeficiency Disorder — Chongqing, China, 2022
por: Yao, Ning, et al.
Publicado: (2022)

Characteristics of an Environmentally Monitored Prolonged Type 2 Vaccine Derived Poliovirus Shedding Episode that Stopped without Intervention
por: Hovi, Tapani, et al.
Publicado: (2013)

Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters
por: Kalkowska, D. A., et al.
Publicado: (2019)

Recombinant Vaccine–Derived Poliovirus in Madagascar
por: Rousset, Dominique, et al.
Publicado: (2003)

Vaccine–derived Poliovirus, Thailand, 2003
por: Tharmaphornpilas, Piyanit
Publicado: (2005)

Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018–2019
por: Zhao, Hehe, et al.
Publicado: (2021)

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure
por: Jallow, Sabelle, et al.
Publicado: (2020)

Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication
por: Aghamohammadi, Asghar, et al.
Publicado: (2017)

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal()
por: Harutyunyan, Vachagan, et al.
Publicado: (2023)

Estimating the Extent of Vaccine-Derived Poliovirus Infection
por: Wringe, Alison, et al.
Publicado: (2008)

Metagenomic sequencing, molecular characterization, and Bayesian phylogenetics of imported type 2 vaccine-derived poliovirus, Spain, 2021
por: Fernandez-Garcia, Maria Dolores, et al.
Publicado: (2023)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
por: Nanteza, Mary Bridget, et al.
Publicado: (2018)

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative
por: Dunn, Glynis, et al.
Publicado: (2015)

Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021
por: O’Connor, Patrick, et al.
Publicado: (2022)

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023
por: Davlantes, Elizabeth, et al.
Publicado: (2023)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

Circulating Vaccine Derived Poliovirus and the polio eradication endgame
por: Davis, Robert, et al.
Publicado: (2012)

Vaccine-Derived Polioviruses, Central African Republic, 2019
por: Joffret, Marie-Line, et al.
Publicado: (2021)

Evaluation of Direct Detection Protocols for Poliovirus from Stool Samples of Acute Flaccid Paralysis Patients
por: Ueno, Minami Kikuchi, et al.
Publicado: (2023)

Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021
por: Yang, Hong, et al.
Publicado: (2023)

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018
por: Bauri, Mathias, et al.
Publicado: (2019)

Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses in Nad Ali District of Southern Afghanistan during June 2009-February 2011
por: Sharif, Salmaan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v5m9t0tf137nsj86o3ctei3k3f